Algorithm Pipeline
Innovative diagnostic tools for detecting rare and hidden disease, based on the world’s largest labeled patient dataset, built to be integrated into existing physician workflows and currently pursuing FDA approval.
Program
Development
Pre-Submission
Validation
Submission
Approval
Low Ejection Fraction
Breakthrough designation*
Pulmonary Hypertension
Hypertrophic Cardiomyopathy
Amyloidosis
Atrial Fibrillation in Normal Sinus Rhythm
Aortic Stenosis
Early Stage Development Programs
*Granted FDA Breakthrough Designation
Low Ejection Fraction
Breakthrough designation*

Phase: Validation
Pulmonary Hypertension

Phase: Development
Hypertrophic Cardiomyopathy

Phase: Development
Amyloidosis

Phase: Development
Atrial Fibrillation in Normal Sinus Rhythm

Phase: Development
Aortic Stenosis

Phase: Development
Early Stage Development Programs

Phase: Development
*Granted FDA Breakthrough Designation

Partner with us!

We’re actively developing algorithms for FDA approval. Please direct partnership and media inquiries to info@anumana.net

404

@2021 Anumana, Inc. All rights reserved.